News | Cath Lab | October 16, 2023

Shimadzu Medical Systems USA Installs First Trinias Score Opera Cardiac Catheterization Lab in the US

Shimadzu Medical Systems USA, a subsidiary of Shimadzu Corporation, announced the first U.S. installation of a Trinias SCORE Opera C12 (ceiling mounted cutting edge angiography system) at Beaufort Memorial Hospital (Beaufort, SC).

October 16, 2023 — Shimadzu Medical Systems USA, a subsidiary of Shimadzu Corporation, announced the first U.S. installation of a Trinias SCORE Opera C12 (ceiling mounted cutting edge angiography system) at Beaufort Memorial Hospital (Beaufort, SC). The system was installed by Shimadzu’s dealer partner, CMS Imaging (North Charleston, SC).  

Beaufort Memorial Hospital marked the 20th anniversary of the Cochrane Heart Center with the opening of its newly renovated cardiac catheterization lab outfitted with the most advanced technology in the nation. As part of expanding the interventional cardiology program, the updated cath lab will help provide rapid and comprehensive care to hundreds of heart patients every year for life-threatening emergencies and scheduled cardiac procedures.  

“The image quality of the advanced digital angiography system will help improve decision making while reducing the radiation exposure and improving patient comfort,” said Stuart Smalheiser, M.D., interventional cardiologist, and medical director of the Beaufort Memorial Cardiac Catheterization program. “We are very excited to work with Shimadzu as a model for their technology in the U.S. and be on the cutting edge with their advanced cath lab imaging technology.”  

Among the critical conditions treated in a cath lab are heart attacks when an artery suddenly becomes blocked, leading to loss of blood flow in the heart muscle. These patients require an urgent, minimally invasive stenting procedure called percutaneous coronary intervention (PCI) that is performed in the cath lab. The stent serves as a scaffold to open the blocked artery and restores blood flow to preserve heart muscle function; otherwise, the heart may be permanently damaged. The life-saving and usually painless stenting procedure offers a quick recovery and return home, and improves a patient’s quality of life.  

In addition to treating emergencies, there are a variety of elective procedures and diagnostic tests performed in the cath lab including angiograms to show how blood is flowing through arteries or veins, angioplasty to open a narrowed or blocked artery and implantation of pacemakers and cardioverter defibrillators (ICD).  

In total, there are approximately 650 heart procedures performed each year in the cath lab at Beaufort Memorial.  

“Investing in this upgraded technology is one more way for Beaufort Memorial to continue to provide the highest-quality care available in the Lowcountry,” said Beaufort Memorial President and CEO Russell Baxley, MHA. “As noted by numerous certifications and awards by accrediting bodies we are committed to providing safe, high quality, patient-centered cardiac care to our community.”  

Beaufort Memorial is home to nationally recognized heart and vascular care, including being named one of only 262 hospitals nationwide to receive the 2023 Platinum Performance Achievement Award SMS-MR-PR-037 | October 2023 Shimadzu Medical Systems USA from the American College of Cardiology’s National Cardiovascular Data Registry (NCDR) for Chest Pain - Myocardial Infraction (MI) and receiving advanced certification from The Joint Commission for Chest Pain and Stroke. 

For more information: www.shimadzu-usa.co


Related Content

News | Cath Lab

March 25, 2026 — Royal Philips has launched its intuitive interventional guidance platform, IntraSight Plus, which is ...

Home March 26, 2026
Home
Feature | Cath Lab | Kyle Hardner

Since receiving FDA approval in 2016, intravascular lithotripsy (IVL) systems have grown in popularity among ...

Home November 14, 2025
Home
News | Cath Lab

Nov. 11, 2025 — FastWave Medical has successfully completed enrollment in its 30-patient coronary feasibility study and ...

Home November 13, 2025
Home
News | Cath Lab

Oct. 28, 2025 — Results from the first-of-its-kind randomized PROCTOR trial found that a strategy of saphenous vein ...

Home November 04, 2025
Home
News | Cath Lab

Oct. 27, 2025 — Results from the PREVUE-VALVE study suggest that there are currently at least 4.7 million people aged 65 ...

Home October 29, 2025
Home
News | Cath Lab

Oct. 25, 2025 — Medtronic plc has announced the launch of the Stedi Extra Support guidewire, designed to enhance ...

Home October 28, 2025
Home
News | Cath Lab

Oct. 27, 2025 — Elixir Medical, a developer of technologies to treat cardiovascular disease, has announced new clinical ...

Home October 28, 2025
Home
News | Cath Lab

Oct. 22, 2025 — Heartflow, Inc. has introduced Heartflow PCI Navigator, the newest addition to the Heartflow One ...

Home October 23, 2025
Home
News | Cath Lab

Oct. 15, 2025 — Stereotaxis recently announced it has obtained CE Mark in Europe and submitted a 510(k) application to ...

Home October 16, 2025
Home
News | Cath Lab

Oct. 7, 2025 — Medtronic has announced the full distribution of the Neuroguard IEP System (Neuroguard) after a ...

Home October 07, 2025
Home
Subscribe Now